Correction to: Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization
Crossref DOI link: https://doi.org/10.1007/s00280-020-04090-4
Published Online: 2020-06-11
Published Print: 2020-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Verheijen, R. B.
Swart, E. L.
Beijnen, J. H.
Schellens, J. H. M.
Huitema, A. D. R.
Steeghs, N.
Text and Data Mining valid from 2020-06-11
Version of Record valid from 2020-06-11
Article History
First Online: 11 June 2020
Free to read: This content has been made available to all.